These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3367085

  • 1. Hepatic 7 alpha-dehydroxylation of bile acid intermediates, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
    Skrede S, Buchmann MS, Björkhem I.
    J Lipid Res; 1988 Feb; 29(2):157-64. PubMed ID: 3367085
    [Abstract] [Full Text] [Related]

  • 2. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Tint GS.
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [Abstract] [Full Text] [Related]

  • 3. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
    Björkhem I, Skrede S, Buchmann MS, East C, Grundy S.
    Hepatology; 1987 Aug; 7(2):266-71. PubMed ID: 3557306
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biosynthesis of cholestanol from intestinal 7 alpha-hydroxy-4-cholesten-3-one.
    Skrede S, Björkhem I.
    J Biol Chem; 1982 Jul 25; 257(14):8363-7. PubMed ID: 7045120
    [Abstract] [Full Text] [Related]

  • 6. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S, Björkhem I, Buchmann MS, Hopen G, Fausa O.
    J Clin Invest; 1985 Feb 25; 75(2):448-55. PubMed ID: 3919058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Studies of the mechanism of the increased biosynthesis of cholestanol in cerebrotendinous xanthomatosis. The activity of delta 5-3 beta-hydroxysteroid dehydrogenase.
    Buchmann MS, Björkhem I, Fausa O, Skrede S.
    Scand J Gastroenterol; 1985 Dec 25; 20(10):1262-6. PubMed ID: 3868019
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
    Buchmann MS, Björkhem I, Lund AM, Skrede S.
    Scand J Clin Lab Invest Suppl; 1986 Dec 25; 184():41-6. PubMed ID: 3109015
    [Abstract] [Full Text] [Related]

  • 12. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation.
    Norlin M, von Bahr S, Bjorkhem I, Wikvall K.
    J Lipid Res; 2003 Aug 25; 44(8):1515-22. PubMed ID: 12777473
    [Abstract] [Full Text] [Related]

  • 13. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors.
    Oftebro H, Björkhem I, Størmer FC, Pedersen JI.
    J Lipid Res; 1981 May 25; 22(4):632-40. PubMed ID: 6792308
    [Abstract] [Full Text] [Related]

  • 14. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
    Björkhem I, Hansson M.
    Biochem Biophys Res Commun; 2010 May 21; 396(1):46-9. PubMed ID: 20494109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
    Honda A, Salen G, Matsuzaki Y, Batta AK, Xu G, Leitersdorf E, Tint GS, Erickson SK, Tanaka N, Shefer S.
    J Lipid Res; 2001 Feb 21; 42(2):291-300. PubMed ID: 11181760
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G, Shefer S, Tint GS, Nicolau G, Dayal B, Batta AK.
    J Clin Invest; 1985 Aug 21; 76(2):744-51. PubMed ID: 4031069
    [Abstract] [Full Text] [Related]

  • 19. On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase.
    Båvner A, Shafaati M, Hansson M, Olin M, Shpitzen S, Meiner V, Leitersdorf E, Björkhem I.
    J Lipid Res; 2010 Sep 21; 51(9):2722-30. PubMed ID: 20511491
    [Abstract] [Full Text] [Related]

  • 20. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
    Salen G.
    Ann Intern Med; 1971 Dec 21; 75(6):843-51. PubMed ID: 5134895
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.